FI70927C - Extration av interferon fraon bakterier - Google Patents

Extration av interferon fraon bakterier Download PDF

Info

Publication number
FI70927C
FI70927C FI813785A FI813785A FI70927C FI 70927 C FI70927 C FI 70927C FI 813785 A FI813785 A FI 813785A FI 813785 A FI813785 A FI 813785A FI 70927 C FI70927 C FI 70927C
Authority
FI
Finland
Prior art keywords
interferon
cells
suspension
liquid
expressing
Prior art date
Application number
FI813785A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI70927B (fi
FI813785L (fi
Inventor
Paul Leibowitz
Marvin J Weinstein
Original Assignee
Essex Laeaekkeet Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essex Laeaekkeet Oy filed Critical Essex Laeaekkeet Oy
Publication of FI813785L publication Critical patent/FI813785L/fi
Publication of FI70927B publication Critical patent/FI70927B/sv
Application granted granted Critical
Publication of FI70927C publication Critical patent/FI70927C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FI813785A 1980-11-26 1981-11-25 Extration av interferon fraon bakterier FI70927C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21042680A 1980-11-26 1980-11-26
US21042680 1980-11-26
US06/221,135 US4315852A (en) 1980-11-26 1980-12-29 Extraction of interferon from bacteria
US22113580 1980-12-29

Publications (3)

Publication Number Publication Date
FI813785L FI813785L (fi) 1982-05-27
FI70927B FI70927B (fi) 1986-07-18
FI70927C true FI70927C (fi) 1986-10-27

Family

ID=26905139

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813785A FI70927C (fi) 1980-11-26 1981-11-25 Extration av interferon fraon bakterier

Country Status (9)

Country Link
US (1) US4315852A (de)
EP (1) EP0052861B1 (de)
CA (1) CA1176980A (de)
DE (1) DE3163675D1 (de)
DK (1) DK158475C (de)
FI (1) FI70927C (de)
HK (1) HK14187A (de)
IE (1) IE51858B1 (de)
IL (1) IL64385A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57069B1 (en) 1980-04-03 1992-04-22 Biogen Inc Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
JP2551746B2 (ja) * 1983-07-19 1996-11-06 サントリー株式会社 改良プラスミドベクタ−およびその利用
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
US4675387A (en) * 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5460956A (en) * 1990-06-04 1995-10-24 Schering Corporation Method for preparing interferon alpha-2 crystals
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
CZ303110B6 (cs) 1998-11-12 2012-04-04 Schering Corporation Zpusob zvýšení výtežku prostredku obsahujícího interferon alfa
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
GB0319601D0 (en) 2003-08-20 2003-09-24 Sandoz Ag Production process
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
HU230758B1 (hu) * 2006-04-12 2018-03-28 Crealta Pharmaceuticals LLC 100% Fehérjék tisztítása kationos felületaktív anyaggal
AU2009330278B2 (en) 2008-12-23 2013-01-31 Merck Sharp & Dohme Corp. Purification of recombinantly produced interferon
EP3482768A1 (de) 2009-06-25 2019-05-15 Horizon Pharma Rheumatology LLC Verfahren und kits zur vorhersage des infusionsreaktionsrisikos und von antikörpervermitteltem antwortverlust durch überwachung der serum-harnsäure während der pegylierten uricase-therapie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699222A (en) * 1958-03-11 1972-10-17 Nat Res Dev Production of viral interfering substances
GB980227A (en) * 1962-08-16 1965-01-13 Glaxo Lab Ltd Purification and/or concentration of material containing interferon
GB1055895A (en) * 1963-12-10 1967-01-18 Glaxo Lab Ltd Interferon purification
US3256152A (en) * 1965-06-14 1966-06-14 Merck & Co Inc Concentration and purification of interferons, viral inhibiting substances (vis), viral inhibiting factors (vif), or viral inhibitory material
EP0005476B1 (de) * 1978-05-17 1981-12-30 Dr. Karl Thomae GmbH Verfahren zur Herstellung von Humaninterferon
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production

Also Published As

Publication number Publication date
CA1176980A (en) 1984-10-30
IL64385A (en) 1984-09-30
EP0052861B1 (de) 1984-05-16
US4315852A (en) 1982-02-16
IE51858B1 (en) 1987-04-15
FI70927B (fi) 1986-07-18
DE3163675D1 (en) 1984-06-20
FI813785L (fi) 1982-05-27
DK523881A (da) 1982-05-27
HK14187A (en) 1987-02-27
DK158475B (da) 1990-05-21
EP0052861A3 (en) 1983-01-26
EP0052861A2 (de) 1982-06-02
DK158475C (da) 1990-10-15
IE812767L (en) 1982-05-26
IL64385A0 (en) 1982-02-28

Similar Documents

Publication Publication Date Title
FI70927C (fi) Extration av interferon fraon bakterier
EP0102989B1 (de) Verfahren zur gewinnung von menschlichem beta-interferon aus einem transformierten mikroorganismus
CA1277272C (en) Purification of pichia produced lipophilic proteins
US4364863A (en) Extraction of interferon from bacteria
US4427580A (en) Method for separation and recovery of proteins and nucleic acids from nucleoproteins using water destructuring salts
SE8402861L (sv) Rening av biologiskt material
NO820943L (no) Fremgangsmaate ved gjenvinning av produkter produsert av vertsorganismer.
DE3687112D1 (de) Verfahren zur ausscheidung von genprodukten in das wachstumsmedium von gram-negativen bakterien.
Lyttleton A simple method of isolating ribosomes from Tetrahymena pyriformis
CN102212547A (zh) 肠三叶因子重组表达载体及肠三叶因子制备方法
EP0291294B1 (de) Extraktion eines Granulocyt-Makrophagen-Koloniestimulierungsfaktors aus Bakterien
JPH0229316B2 (de)
Kite et al. Nuclear and plastid DNAs from the binucleate dinoflagellates Glenodinium (Peridinium) foliaceum and Peridinium balticum
Biedermann et al. Release of periplasmic enzymes from Escherichia coli using tangential flow filtration
Phillips et al. [4] Large-scale production of human interferon from lymphoblastoid cells
EP0227833A1 (de) Verfahren zur herstellung von heteroproteinen
RU1770359C (ru) Рекомбинантна плазмидна ДНК pJDB (MSIL), обеспечивающа синтез интерлейкина-2 человека в клетках дрожжей SасснаRомUсеS ceReUISIaL, способ ее получени и штамм дрожжей SасснаRомYсеS ceReUISIaL - продуцент интерлейкина-2 человека
JPH0380469B2 (de)
EA044473B1 (ru) Рекомбинантная плазмида, способ её конструирования и штамм дрожжей komagataella pastoris - продуцент иммунного интерферона-гамма собаки
Ramlan et al. Purification of High Molecular Weight Outer Membrane Proteins of Pasteurella Multocida Type 2: B
JPS5934898A (ja) 微生物が産生するヒトインタ−フエロン−βの精製方法
JPH02227076A (ja) 遺伝子組換え菌で製造された不溶性蛋白質の活性化法
JPH0616715B2 (ja) 融合蛋白質の精製方法

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ESSEX LAEAEKKEET OY